Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-06-09
1996-03-26
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540523, A61K 3155, C07D22316
Patent
active
055020488
ABSTRACT:
Antagonists at the NMDA receptor complex which are benz b!azepines having a hydroxy, alkoxy or amino substituent at the 3-position and a 4-position alkenyl, alkynyl, aryl or heteroaryl substituent for treatment of stroke and/or other neurodegenerative disorders.
REFERENCES:
patent: 4410520 (1983-10-01), Watthey
patent: 4473575 (1984-09-01), Watthey
patent: 4477446 (1984-10-01), Jones
patent: 4575503 (1986-03-01), Watthey
patent: 4885364 (1989-12-01), Thottathil
patent: 5051442 (1991-09-01), Salituro et al.
patent: 5182366 (1993-01-01), Huebner et al.
patent: 5189054 (1993-02-01), Salituro et al.
patent: 5229413 (1993-07-01), Gray et al.
patent: 5266684 (1993-11-01), Rutter et al.
patent: 5322776 (1994-06-01), Knopf et al.
patent: 5322943 (1994-06-01), McCall et al.
patent: 5330768 (1994-07-01), Park et al.
Solomon's Organic Chemistry 2nd Edition, 1980, p. 697.
Glutamate Neurotoxicity and Diseases of the Nervous System, Neuron, vol. 1, 623-634 Oct. 1988.
Journal of Medicine Chemistry, American Chemical Society, vol. 37, #24, Nov. 1994.
J. Med. Chem., American Chemical Society, 1994, 37, 1402-1405.
J. Med. Chem., American Chemical Society, 1992, 35, 3423-3425.
J. Org. Chem., 40, 3874 (1975).
Can. J. Chem., 52, 610, (1974).
J. Heterocyclic Chem., 26, 793, (1989).
Molecular Pharmacology, 41:1130-1141 (1992).
Kokoko Pat. No. Sho. 49-28754 (1974) (translation provided) (JP).
Kokoko Pat. No. Sho. 49-28753 (1974) (translation provided) (JP).
Abstract of EP-166-353-A n. d.
Abstract of EP-166-357-A n. d.
Abstract of EP-166-354-A n. d.
Abstract of US 4,692,522 n. d.
Abstract of US 4,757,068 n. d.
Abstract of EP-322-779-A n. d.
Abstract of ZA 8303-903-A n. d.
Abstract of EP-107-095-A n. d.
Abstract of ZA 8309-532-A n. d.
Abstract of US 3,989,689 n. d.
Abstract of Jap. 4028-754 n. d.
Abstract of US 4,477,446 n. d.
Abstract of US 3,949,081 n. d.
Abstract of US 4,965,356 n. d.
Abstract of EP 400-665-A n. d.
Chemical Abstracts, 82, 1975, 614.
J. Med. Chem. 1990, 33, 2944-2946.
J. Med. Chem. 1994, 37, 1402-1405.
J. Med. Chem. 1990, 33, 3130-3132.
J. Med. Chem. 1992, 35, 3423-3425.
Abstract, 206th ACS Mtg. Chicago, 1993, MEDI 183.
Abstract #B-73, 33rd National Organic Chemistry Symposium n. d.
The Pharmacologist, vol. 35-#3, 1993.
Neuroscience Research Communications, vol. 8, #3, 1991.
International Search Report Oct. 13, 1994.
Chapdelaine Marc J.
Davenport Timothy W.
Garcia-Davenport Laura E.
Jackson Paul F.
McKinney Jeffrey A.
Alexander Michael D.
Bond Robert T.
Newtson Ruth H.
Zeneca Limited
LandOfFree
Substituted nitrogen heterocycles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted nitrogen heterocycles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted nitrogen heterocycles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-915726